$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM
12:00pm, Saturday, 07'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM). Such investors are ad
A Suit Has Been Filed Against DexCom, Inc. And Shareholder Participation Is Urged By The Schall Law Firm
11:00am, Saturday, 07'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "th
NEW YORK, Sept. 07, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Compa
October 21, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against DXCM
06:45pm, Friday, 06'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
06:00pm, Friday, 06'th Sep 2024
LOS ANGELES , Sept. 6, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit agai
October 21, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against DXCM
04:40pm, Friday, 06'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
04:29pm, Friday, 06'th Sep 2024
NEW YORK , Sept. 6, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all purchasers of securities of DexCom, Inc
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit – DXCM
04:00pm, Friday, 06'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "th
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. (DXCM) Shareholders
08:45am, Friday, 06'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ:DXCM) and certain of the Com
Investors who lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM
07:15am, Friday, 06'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
Sign In
Buy DXCM